High costs and uneven insurance coverage keep wearable heart monitors out of reach for many women, according to Lindsey Valenzuela, PharmD, APh, BCACP, vice president of population health integration ...

When pharmacists practice in value-based care settings, their impact on arrhythmia management expands far beyond medication ...

Key to cost containment lies in partnering with transparent PBMs, a more thoughtful approach to prescribing GLP-1s and ...

Becker's asked pharmacy executives from hospitals and health systems across the U.S. to share the most underappreciated trends in healthcare today. The ...

Provides a Differentiated Cost-Sharing Framework for GLP-1 Medications Paired With Clinical Oversight and Proven Behavior Change Support from WeightWatchers Clinic ...

Becker's asked pharmacy executives from hospitals and health systems, along with academic medical centers and universities across the U.S. to share ...

Please provide your email address to receive an email when new articles are posted on . Medicare Part D beneficiaries had an increase in out-of-pocket spending for GLP-1s approved for diabetes in 2025 ...

"As of now, semaglutide is FDA-indicated for slowing chronic kidney disease progression, [but] our results suggest that ...

The University of Arkansas' Osher Lifelong Learning Institute and various local organizations are hosting a series of educational classes, events, and community initiatives in Northwest Arkansas, ...

MINNEAPOLIS, MN—Fewer than one-quarter of patients who have heart failure with reduced ejection (HFrEF) and no clinical ...

WeightWatchers has launched a first-of-its-kind solution that combines direct pricing from pharmaceutical manufacturers with flexible employer subsidy coverage for GLP-1 therapies for weight loss.

When nearly 6 in 10 Americans feel under the weather, they’re more likely to turn to a pharmacist than a physician, 2024 ...